AI assistant
Sending…
Core Laboratories Inc. /DE/ — Director's Dealing 2024
Mar 27, 2024
32685_dirs_2024-03-27_f6e34ba5-d32e-4a9e-806e-f0084aba1eb5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Core Laboratories Inc. /DE/ (CLB)
CIK: 0001958086
Period of Report: 2024-03-21
Reporting Person: Teo Sow Hang (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 6514.334 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Restricted Shares | $ | Common Stock (9940) | Direct |
Footnotes
F1: Restricted Shares will vest in accordance with the time-based vesting schedule for each share award over a six-year period following the respective grant date. Mr. Teo has 6 awards outstanding, and of those the following number of shares remain unvested: 80 shares from the award on August 1, 2018; 350 shares from the award on May 1, 2019; 600 shares from the award on August 1, 2020; 750 shares from the award on October 1, 2020; 960 shares from the award on August 1, 2021; and 7,200 shares from the award on December 1, 2023.
More from Core Laboratories Inc. /DE/
Regulatory Filings
2026
May 15
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 17
Director's Dealing
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 17
Director's Dealing
2026
Feb 17
Director's Dealing
2026
Feb 17
Director's Dealing
2026
Feb 17
Regulatory Filings
2026
Feb 4